GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ritter Pharmaceuticals Inc (NAS:RTTR) » Definitions » PB Ratio

Ritter Pharmaceuticals (Ritter Pharmaceuticals) PB Ratio : 4.33 (As of Jun. 05, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Ritter Pharmaceuticals PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-06-05), Ritter Pharmaceuticals's share price is $0.45. Ritter Pharmaceuticals's Book Value per Share for the quarter that ended in Mar. 2020 was $0.10. Hence, Ritter Pharmaceuticals's PB Ratio of today is 4.33.

The historical rank and industry rank for Ritter Pharmaceuticals's PB Ratio or its related term are showing as below:

RTTR's PB Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 2.55
* Ranked among companies with meaningful PB Ratio only.

Back to Basics: PB Ratio


Ritter Pharmaceuticals PB Ratio Historical Data

The historical data trend for Ritter Pharmaceuticals's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ritter Pharmaceuticals PB Ratio Chart

Ritter Pharmaceuticals Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
PB Ratio
Get a 7-Day Free Trial 24.84 191.87 27.13 69.12 -

Ritter Pharmaceuticals Quarterly Data
Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 948.26 - - - 64.23

Competitive Comparison of Ritter Pharmaceuticals's PB Ratio

For the Biotechnology subindustry, Ritter Pharmaceuticals's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ritter Pharmaceuticals's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ritter Pharmaceuticals's PB Ratio distribution charts can be found below:

* The bar in red indicates where Ritter Pharmaceuticals's PB Ratio falls into.



Ritter Pharmaceuticals PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Ritter Pharmaceuticals's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Mar. 2020)
=0.45/0.104
=4.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Ritter Pharmaceuticals  (NAS:RTTR) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Ritter Pharmaceuticals PB Ratio Related Terms

Thank you for viewing the detailed overview of Ritter Pharmaceuticals's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Ritter Pharmaceuticals (Ritter Pharmaceuticals) Business Description

Traded in Other Exchanges
N/A
Address
1880 Century Park East, Suite 1000, Los Angeles, CA, USA, 90067
Ritter Pharmaceuticals Inc develops novel therapeutic products that modulate the gut microbiome to treat gastrointestinal diseases. Its lead product, RP-G28 is designed to stimulate the growth of lactose-metabolizing bacteria in the colon thereby effectively adapting the gut microbiome to assist in digesting lactose that reaches the large intestine.
Executives
Amy S. Broidrick director 1440 VALLE GRANDE, ESCONDIDO CA 92025
Sekisui Diagnostics, Llc 10 percent owner 1 WALL STREET, BURLINGTON MA 01803
Ira E. Ritter director C/O RITTER PHARMACEUTICALS INC., 1801 CENTURY PARK EAST, SUITE 1820, LOS ANGELES CA 90096
Matthew E Korenberg director 11119 NORTH TORREY PINES ROAD, SUITE 200, LA JOLLA CA 92037
Kurt H Kruger director 100 FOXBOROUGH BLVD, SUITE 240, FOXBOROUGH MA 02035
Michael S. Poirier director, officer: Chairman, President & CEO 2042 CORTE DEL NOGAL, SUITE B, CARLSBAD CA 92011
Christopher L. Lotz officer: Vice President of Finance, CFO 2042 CORTE DEL NOGAL, SUITE B, CARLSBAD CA 90211
Shishir K. Sinha officer: Vice President of Operations 2042 CORTE DEL NOGAL, SUITE B, CARLSBAD CA 92011
Richard A. David director 2042 CORTE DEL NOGAL, SUITE B, CARLSBAD CA 92011
Wajdi Abdul-ahad officer: Vice President, R & D, CSO 2042 CORTE DEL NOGAL, SUITE B, CARLSBAD CA 92011
Andrew J Ritter director, officer: CEO and President C/O RITTER PHARMACEUTICALS INC., 1801 CENTURY PARK EAST, SUITE 1820, LOS ANGELES CA 90096
John W Beck officer: Chief Financial Officer C/O RITTER PHARMACEUTICALS, INC., 1880 CENTURY PARK EAST, SUITE 1000, LOS ANGELES CA 90067
Noah Doyle director C/O RITTER PHARMACEUTICALS INC., 1801 CENTURY PARK EAST, SUITE 1820, LOS ANGELES CA 90096
Matthew W Foehr director 11119 NORTH TORREY PINES RD #200, LA JOLLA CA 92037
Paul V Maier director 3595 JOHN HOPKINS COURT, SAN DIEGO CA 92121

Ritter Pharmaceuticals (Ritter Pharmaceuticals) Headlines

From GuruFocus